272 related articles for article (PubMed ID: 22032647)
1. ROS generation via NOX4 and its utility in the cytological diagnosis of urothelial carcinoma of the urinary bladder.
Shimada K; Fujii T; Anai S; Fujimoto K; Konishi N
BMC Urol; 2011 Oct; 11():22. PubMed ID: 22032647
[TBL] [Abstract][Full Text] [Related]
2. p16 INK4a overexpression and p16/Ki-67 dual labeling versus conventional urinary cytology in the evaluation of urothelial carcinoma.
Piaton E; Carré C; Advenier AS; Decaussin-Petrucci M; Mège-Lechevallier F; Lantier P; Granier G; Ruffion A
Cancer Cytopathol; 2014 Mar; 122(3):211-20. PubMed ID: 24302621
[TBL] [Abstract][Full Text] [Related]
3. ALKBH3 contributes to survival and angiogenesis of human urothelial carcinoma cells through NADPH oxidase and tweak/Fn14/VEGF signals.
Shimada K; Fujii T; Tsujikawa K; Anai S; Fujimoto K; Konishi N
Clin Cancer Res; 2012 Oct; 18(19):5247-55. PubMed ID: 22850567
[TBL] [Abstract][Full Text] [Related]
4. Cytokeratin 20 immunocytochemistry on urine sediments: A potential low-cost adjunct to cytology in the diagnosis of low-grade urothelial carcinoma.
Wadhwa N; Diwaker P; Lotha N; Arora VK; Singh N
Cytopathology; 2017 Dec; 28(6):531-535. PubMed ID: 28940433
[TBL] [Abstract][Full Text] [Related]
5. p16/Ki-67 dual labeling and urinary cytology results according to the New Paris System for Reporting Urinary Cytology: Impact of extended follow-up.
Piaton E; Advenier AS; Carré C; Decaussin-Petrucci M; Mège-Lechevallier F; Hutin K; Nennig C; Colombel M; Ruffion A
Cancer Cytopathol; 2017 Jul; 125(7):552-562. PubMed ID: 28371465
[TBL] [Abstract][Full Text] [Related]
6. Human Epidermal Growth Factor Receptor 2 Overexpression in Micropapillary and Other Variants of Urothelial Carcinoma.
Behzatoğlu K; Yörükoğlu K; Demir H; Bal N
Eur Urol Focus; 2018 Apr; 4(3):399-404. PubMed ID: 28753766
[TBL] [Abstract][Full Text] [Related]
7. Detection of pagetoid urothelial intraepithelial neoplasia extending to the vagina by cervical screening cytology: a case report with renewed immunochemical summary.
Koyanagi Y; Kubo C; Nagata S; Ryu A; Hatano K; Kano R; Tanada S; Ashimura JI; Idota A; Kamiura S; Yamasaki T; Nakatsuka SI
Diagn Pathol; 2019 Feb; 14(1):9. PubMed ID: 30711015
[TBL] [Abstract][Full Text] [Related]
8. [Value of CK20 immunocytochemistry as an adjuvant to urine liquid-based cytology in detection of urothelial carcinoma].
Li M; Li HX; Guo HQ; Zhao H; Zhao LL; Ma JH; Li CL; Cao J; Pan QJ
Zhonghua Zhong Liu Za Zhi; 2012 Sep; 34(9):669-73. PubMed ID: 23159079
[TBL] [Abstract][Full Text] [Related]
9. The combination cytology/epichek test in non muscle invasive bladder carcinoma follow-up: Effective tool or useless expence?
Pierconti F; Martini M; Fiorentino V; Cenci T; Capodimonti S; Straccia P; Sacco E; Pugliese D; Cindolo L; Larocca LM; Bassi PF
Urol Oncol; 2021 Feb; 39(2):131.e17-131.e21. PubMed ID: 32773233
[TBL] [Abstract][Full Text] [Related]
10. Critical role of Nox4-based NADPH oxidase in glucose-induced oxidative stress in the kidney: implications in type 2 diabetic nephropathy.
Sedeek M; Callera G; Montezano A; Gutsol A; Heitz F; Szyndralewiez C; Page P; Kennedy CR; Burns KD; Touyz RM; Hébert RL
Am J Physiol Renal Physiol; 2010 Dec; 299(6):F1348-58. PubMed ID: 20630933
[TBL] [Abstract][Full Text] [Related]
11. A novel human AlkB homologue, ALKBH8, contributes to human bladder cancer progression.
Shimada K; Nakamura M; Anai S; De Velasco M; Tanaka M; Tsujikawa K; Ouji Y; Konishi N
Cancer Res; 2009 Apr; 69(7):3157-64. PubMed ID: 19293182
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic value of a comprehensive, urothelial carcinoma-specific next-generation sequencing panel in urine cytology and bladder tumor specimens.
Sun T; Hutchinson L; Tomaszewicz K; Caporelli ML; Meng X; McCauley K; Fischer AH; Cosar EF; Cornejo KM
Cancer Cytopathol; 2021 Jul; 129(7):537-547. PubMed ID: 33539671
[TBL] [Abstract][Full Text] [Related]
13. The use of urinary nuclear matrix protein 22 (NMP22) as a diagnostic adjunct to urine cytology for monitoring of recurrent bladder cancer--institutional experience and review.
Önal B; Han Ü; Yilmaz S; Köybasioglu F; Altuğ U
Diagn Cytopathol; 2015 Apr; 43(4):307-14. PubMed ID: 25488052
[TBL] [Abstract][Full Text] [Related]
14. [Comparison of perioperative methylene blue-stained and permanent Papanicolaou-stained urine cytology to detect patients with high-grade urothelial cancer or the urinary bladder. Part 1].
Rossi R; Jaeger T; Börgermann C; Furtkamp C; Moos Stahl R; Rübben H; vom Dorp F
Urologe A; 2007 Sep; 46(9):1145-7. PubMed ID: 17661004
[TBL] [Abstract][Full Text] [Related]
15. Immunocytochemical staining for p53 and Ki-67 helps to characterise urothelial cells in urine cytology.
Courtade-Saïdi M; Aziza J; d'Aure D; Bérard E; Evrard S; Basset C; Lacoste-Collin L
Cytopathology; 2016 Dec; 27(6):456-464. PubMed ID: 27873391
[TBL] [Abstract][Full Text] [Related]
16. Cyclooxygenase-2 expression on urothelial and inflammatory cells of cystoscopic biopsies and urine cytology as a possible predictive marker for bladder carcinoma.
Moussa M; Omran Z; Nosseir M; Lotfy A; Swellam T
APMIS; 2009 Jan; 117(1):45-52. PubMed ID: 19161536
[TBL] [Abstract][Full Text] [Related]
17. Dual immunocytochemical staining of annexin A10 and p53 in low-grade and papillary urothelial carcinoma contributes to improvement of diagnostic accuracy in urine cytology.
Kobayashi G; Hayashi T; Sentani K; Uraoka N; Shibata J; Nobuhiro R; Saito Y; Ishida K; Kaneko Y; Ikeda K; Hanamoto M; Nose H; Arihiro K; Hinata N; Oue N
Cancer Cytopathol; 2023 Sep; 131(9):548-560. PubMed ID: 37300383
[TBL] [Abstract][Full Text] [Related]
18. The emerging role of ROS-generating NADPH oxidase NOX4 in DNA-damage responses.
Weyemi U; Dupuy C
Mutat Res; 2012; 751(2):77-81. PubMed ID: 22580379
[TBL] [Abstract][Full Text] [Related]
19. Detection of urinary bladder cancer with flow cytometry and hexaminolevulinate in urine samples.
Cunderlíková B; Wahlqvist R; Berner A; Vasovic V; Warloe T; Nesland JM; Peng Q
Cytopathology; 2007 Apr; 18(2):87-95. PubMed ID: 17397493
[TBL] [Abstract][Full Text] [Related]
20. p16ink4 immunoreactivity is a reliable marker for urothelial carcinoma in situ.
Yin M; Bastacky S; Parwani AV; McHale T; Dhir R
Hum Pathol; 2008 Apr; 39(4):527-35. PubMed ID: 18234280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
